Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Martin, Moorhead"'
Autor:
Annie Tanenhaus, Timothy Stowe, Andrew Young, John McLaughlin, Rangoli Aeran, I. Winnie Lin, Jianmin Li, Raghavendra Hosur, Ming Chen, Jennifer Leedy, Tiffany Chou, Sirika Pillay, Maria Candida Vila, Jennifer A. Kearney, Martin Moorhead, Archana Belle, Stephanie Tagliatela
Publikováno v:
Human Gene Therapy. 33:579-597
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a0ed1796b13d7b4e30d306b12d32a09
https://doi.org/10.1089/hum.2022.037
https://doi.org/10.1089/hum.2022.037
Autor:
Carolina Schinke, Antje Hoering, Hongwei Wang, Victoria Carlton, Sharmilan Thanandrarajan, Shayu Deshpande, Purvi Patel, Gabor Molnar, Sandra Susanibar, Meera Mohan, Pankaj Mathur, Muthukumar Radhakrishnan, Shadiqul Hoque, Jorge Jo Kamimoto, Monica Grazziutti, Frits van Rhee, Maurizio Zangari, Giovanni Insuasti-Beltran, Daisy Alapat, Ginell Post, Shmuel Yaccoby, Joshua Epstein, Leo Rasche, Sarah Johnson, Martin Moorhead, Tom Willis, Bart Barlogie, Brian Walker, Niels Weinhold, Faith E Davies, Gareth J. Morgan
Publikováno v:
Haematologica, Vol 102, Iss 8 (2017)
Externí odkaz:
https://doaj.org/article/f623ed3fc1294693a16e2270ad7ee5e1
Autor:
Mark Klinger, Francois Pepin, Jen Wilkins, Thomas Asbury, Tobias Wittkop, Jianbiao Zheng, Martin Moorhead, Malek Faham
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141561 (2015)
Monitoring antigen-specific T cells is critical for the study of immune responses and development of biomarkers and immunotherapeutics. We developed a novel multiplex assay that combines conventional immune monitoring techniques and immune receptor r
Externí odkaz:
https://doaj.org/article/5e07b9e6e82e43fdb44cf1bbe5b395fa
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74231 (2013)
In this study, we combined a novel sequencing method, which can identify individual clonotypes based on their unique T cell receptor (TCR) rearrangement, with existing immune assays to characterize antigen-specific T cell responses. We validated this
Externí odkaz:
https://doaj.org/article/3c0b400766774c81a49228d135ae0fd6
Autor:
Philippe Moreau, Laurent Garderet, Bertrand Arnulf, Sabrina Maheo, Lotfi Benboubker, Mamoun Dib, Sabine Brechignac, Nelly Robillard, Mohamad Mohty, Margaret Macro, Brigitte Pegourie, Thierry Facon, Brigitte Kolb, Karim Belhadj, Nikhil C. Munshi, Bruno Royer, Olivier Decaux, Arnaud Jaccard, Valérie Lauwers-Cances, Marie-Lorraine Chretien, Anne-Marie Stoppa, Hervé Avet-Loiseau, Xavier Leleu, Kenneth C. Anderson, Jean-Richard Eveillard, Martin Moorhead, Chantal Doyen, Cecile Fohrer, Lionel Karlin, Jill Corre, Victoria Carlton, Paul G. Richardson, Malek Faham, Jean-Luc Harousseau, Michel Attal, Nathalie Meuleman, Thomas D. Willis, Aurore Perrot, Cyrille Hulin, Thomas Dejoie
Publikováno v:
Blood
Blood, American Society of Hematology, 2018, 132 (23), pp.2456-2464. ⟨10.1182/blood-2018-06-858613⟩
Blood, Vol. 132, no. 23, p. 2456-2464 (2018)
Blood, American Society of Hematology, 2018, 132 (23), pp.2456-2464. ⟨10.1182/blood-2018-06-858613⟩
Blood, Vol. 132, no. 23, p. 2456-2464 (2018)
IF 15.132 (2017); International audience; The introduction of novel agents has led to major improvements in clinical outcomes for patients with multiple myeloma. To shorten evaluation times for new treatments, health agencies are currently examining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500fa1b818ac6de4e41772025c8d41b8
https://doi.org/10.1182/blood-2018-06-858613
https://doi.org/10.1182/blood-2018-06-858613
Autor:
Yoshitaka Zaimoku, Yasushi Terasaki, Tsutomu Sato, Martin Moorhead, Shinji Nakao, Katherine A. Kong, Naoki Takezako, Kenji Yokoyama, Hiroyuki Takamatsu, Hideo Yagi, Ryoichi Murata, Malek Faham, Morio Matsumoto, Rachel K Wee, Shigeki Ito, Victoria Carlton, Kinya Ohata, Toshiro Kurokawa, Takashi Yoshida, Toshihiro Miyamoto, Kosei Matsue, Jianbiao Zheng
Publikováno v:
British Journal of Haematology. 183:664-668
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84dd63a8387cdf35282c76d82a08f300
https://doi.org/10.1111/bjh.15002
https://doi.org/10.1111/bjh.15002
Autor:
Kosei Matsue, Tomotaka Yoshida, Malek Faham, Tsutomu Sato, Martin Moorhead, Shigeki Ito, Victoria Carlton, Hiroyuki Takamatsu, Jianbiao Zheng, Toshiro Kurokawa, Shinji Nakao, Ryoichi Murata, Kinya Ohata, Naoki Takezako, Morio Matsumoto, Hideo Yagi, Katherine A. Kong, Kozue Yokoyama, Yasushi Terasaki, Toshihiro Miyamoto
Publikováno v:
Annals of Oncology
Background Most patients with multiple myeloma (MM) are considered to be incurable, and relapse owing to minimal residual disease (MRD) is the main cause of death among these patients. Therefore, new technologies to assess deeper response are require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705b370a018a34ac2cb1cb736fe2f905
http://europepmc.org/articles/PMC5834061
http://europepmc.org/articles/PMC5834061
Autor:
Sharmilan Thanandrarajan, Giovanni Insuasti-Beltran, Antje Hoering, Shayu Deshpande, Faith E. Davies, Brian A Walker, Sandra Susanibar, Purvi Patel, Martin Moorhead, Monica Grazziutti, Shmuel Yaccoby, Ginell R. Post, Muthukumar Radhakrishnan, Frits van Rhee, Shadiqul Hoque, Sarah K. Johnson, Leo Rasche, Niels Weinhold, Gareth J. Morgan, Meera Mohan, Bart Barlogie, Pankaj Mathur, Carolina Schinke, Maurizio Zangari, Daisy Alapat, Thomas D. Willis, Jorge Jo Kamimoto, Gabor Molnar, Victoria Carlton, Joshua Epstein, Hongwei Wang
Publikováno v:
Haematologica. 102:e313-e316
Complete remission (CR) rates for multiple myeloma (MM) have increased to 60% with current treatment approaches, including high dose melphalan-based autologous stem cell transplant (ASCT) and novel agents, and are associated with improved survival.[1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07cb71517158c03de8a3e08ac1a545d9
https://doi.org/10.3324/haematol.2017.165217
https://doi.org/10.3324/haematol.2017.165217
Autor:
Peder Lund, Samhita Rao, Malek Faham, Joshua E. Elias, Niclas Olsson, Debra K. Czerwinski, Lisa E. Wagar, Henning Stehr, Chih Long Liu, Michael S. Khodadoust, Caleb D. Marceau, Binbin Chen, Keith Rawson, Kavya Swaminathan, Lichao Zhang, Victoria Carlton, Ronald Levy, Martin Moorhead, Ole Audun Werner Haabeth, Ash A. Alizadeh, Jan E. Carette, Holbrook E Kohrt, Michael R. Green, Aaron M. Newman, David F. Steiner, Mark M. Davis
Publikováno v:
Nature
Nature, vol 543, iss 7647
Nature, vol 543, iss 7647
Cancer somatic mutations can generate neoantigens that distinguish malignant from normal cells. However, the personalized identification and validation of neoantigens remains a major challenge. Here we discover neoantigens in human mantle-cell lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aff82c63e959264603cb107aff7a617
https://doi.org/10.1038/nature21433
https://doi.org/10.1038/nature21433
Autor:
Aaron C Logan, David B. Miklos, Jianbiao Zheng, James L. Zehnder, Amna Waqar, Malek Faham, Mark R. Krampf, Balasubramanian Narasimhan, Carol D. Jones, Bing Zhang, Victoria Carlton, Martin Moorhead
Publikováno v:
Leukemia
Quantification of minimal residual disease (MRD) following allogeneic hematopoietic cell transplantation (allo-HCT) predicts post-transplant relapse in patients with chronic lymphocytic leukemia (CLL). We utilized an MRD-quantification method that am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::687b21a1d7c62b1847bdc12f7dbadc45
https://doi.org/10.1038/leu.2013.52
https://doi.org/10.1038/leu.2013.52